Jayarajan Senthil Nathan, Vlada Claudiu Adrian, Sanchez Luis Arturo, Jim Jeffrey
Section of Vascular and Endovascular Surgery, Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA.
University Vascular Associates, Los Angeles, CA, USA.
Vascular. 2020 Dec;28(6):697-704. doi: 10.1177/1708538120930458. Epub 2020 Jun 6.
In recent decades, there has been a shift in the management of aortic abdominal aneurysm from open intervention (open aortic aneurysm repair) to an endovascular approach (endovascular aortic aneurysm repair). This shift has yielded clinical as well as socioeconomic reverberations. In our current study, we aim to analyze these effects brought about by the switch to endovascular treatment and to scrutinize the determinants of cost variations between the two treatment modalities.
The National (Nationwide) Inpatient Sample database was queried for clinical data ranging from 2001 to 2013 using International Classification of Disease, 9th Revision (ICD-9) codes for open and endovascular aortic repair. Clinical parameters and financial data related to the two treatment modalities were analyzed. Temporal trends of index hospitalization costs were determined. Multivariate linear regression was used to characterize determinants of cost for endovascular aneurysm repair and open abdominal aortic aneurysm repair.
A total of 128,154 aortic repairs were captured in our analysis, including 62,871 open repairs and 65,283 endovascular repairs. Over the assessed time period, there has been a decrease in the cost of elective endovascular aortic aneurysm repair from $34,975.62 to $31,384.90, a $3,590.72 difference ( < 0.01), while the cost of open aortic repair has increased from $37,427.77 to $43,640.79 by 2013, a $6,212.79 increase ( < 0.01). The cost of open aortic aneurysm repair disproportionately increased at urban teaching hospitals, where by 2013, it costs $50,205.59, compared to $34,676.46 at urban nonteaching hospitals, and $34,696.97 at rural institutions. Urban teaching hospitals were found to perform an increasing proportion of complex open aneurysm repairs, involving concomitant renal and visceral bypass procedures. On multivariate analysis, strong determinants of cost increase for both endovascular aortic aneurysm repair and open aortic aneurysm repair are rupture status, prolonged length of stay, occurrence of complications, and the need for disposition to a nursing facility or another acute care institution.
As the vascular community has shifted from an open repair of abdominal aortic aneurysm to an endovascular approach, a number of unforeseen clinical and economic effects were noted. We have characterized these ramifications to help guide further clinical decision and resource allocation.
近几十年来,腹主动脉瘤的治疗方式已从开放手术干预(开放性主动脉瘤修复术)转向血管内治疗方法(血管内主动脉瘤修复术)。这种转变产生了临床以及社会经济方面的影响。在我们当前的研究中,我们旨在分析转向血管内治疗所带来的这些影响,并仔细研究两种治疗方式之间成本差异的决定因素。
使用国际疾病分类第九版(ICD - 9)编码,在国家(全国性)住院患者样本数据库中查询2001年至2013年期间开放性和血管内主动脉修复的临床数据。分析了与这两种治疗方式相关的临床参数和财务数据。确定了指数住院费用的时间趋势。采用多元线性回归来描述血管内动脉瘤修复和开放性腹主动脉瘤修复成本的决定因素。
我们的分析共纳入了128,154例主动脉修复病例,其中包括62,871例开放性修复和65,283例血管内修复。在评估的时间段内,择期血管内主动脉瘤修复的成本从34,975.62美元降至31,384.90美元,相差3,590.72美元(<0.01),而开放性主动脉修复的成本到2013年已从37,427.77美元增至43,640.79美元,增加了6,212.79美元(<0.01)。开放性主动脉瘤修复的成本在城市教学医院增加尤为显著,到2013年,其成本为50,205.59美元,相比之下,城市非教学医院为34,676.46美元,农村机构为34,696.97美元。发现城市教学医院进行的复杂开放性动脉瘤修复比例增加,包括同时进行肾和内脏搭桥手术。多因素分析显示,血管内主动脉瘤修复和开放性主动脉瘤修复成本增加的主要决定因素是破裂状态、住院时间延长、并发症的发生以及转至护理机构或其他急性护理机构的需求。
随着血管外科领域从开放性腹主动脉瘤修复转向血管内治疗方法,出现了一些意想不到的临床和经济影响。我们已描述了这些影响,以帮助指导进一步的临床决策和资源分配。